BCL2L1 and head and neck squamous cell carcinoma: For example, co-targeting MCL-1 and BCL-XL resulted in reduced cell viability of cells isolated from squamous cell carcinoma of the head and neck (SCCHN), in in vitro and in vivo models [20].